课题基金 / 基金详情

PLACEBO CONTROLLED STUDY OF SAFETY OF PMPA IN HIV+ PATIENTS

PLACEBO CONTROLLED STUDY OF SAFETY OF PMPA IN HIV+ PATIENTS
PMPA 对 HIV 患者的安全性安慰剂对照研究
批准号:
6297550
负责人:
PATRICIA A BARDITCH-CROVO
金额:
$0.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

PATRICIA A BARDITCH-CROVO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
All subject evaluations have been completed. In this study, PMPA prodrug demonstrated dose-related anti-HIV effect at the end of 28 days of dosing; median log10 decreases in HIV RNA from baseline were 0.32, 0.44, and 1.22. Pharmacokinetic data obtained in this study showed that exposure was dose related and that the serum half life was > 17 hours. Data obtained from this study are being used to choose doses and dosing regimens for the Phase II larger trials that are being designed at the current time
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II SEQUENTIAL COHORT 3 DOSE LEVELS OF ORAL ADEFOVIR DIPIVOXIL
  • 批准号:
    6114401
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    1998
  • 负责人:
    PATRICIA A BARDITCH-CROVO
  • 依托单位:
QUANTIFY RETENTION OF NONOXYNOL IN OPEN LABEL, RANDOMIZED CROSS OVER STUDY
  • 批准号:
    6114294
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    1998
  • 负责人:
    PATRICIA A BARDITCH-CROVO
  • 依托单位:
PHASE I/II ANTIVIRAL ACTIVITY OF 9R2, PROPYLADENINE (PMPA) IN HIV INFECTION
  • 批准号:
    6218234
  • 项目类别:
  • 资助金额:
    $0.23万
  • 财政年份:
    1998
  • 负责人:
    PATRICIA A BARDITCH-CROVO
  • 依托单位:
PHASE I/II ANTIVIRAL ACTIVITY OF 9R2, PROPYLADENINE (PMPA) IN HIV INFECTION
  • 批准号:
    6297522
  • 项目类别:
  • 资助金额:
    $0.23万
  • 财政年份:
    1998
  • 负责人:
    PATRICIA A BARDITCH-CROVO
  • 依托单位:
海外基金